Phase I/II trial of reovirus in combination with cyclophosphamide in patients with advanced treatment-refractory solid tumours.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 09 May 2008
At a glance
- Drugs Cyclophosphamide; Pelareorep
- Indications Lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 09 May 2008 Status changed from initiated to recruiting according to media release from Ocolytics Biotech.
- 12 Nov 2007 New trial record.